Answering four research questions:• Do adults with ASD report less complaints of depression after the mindfulness training when compared to prior the training?• Do adults with ASD have significant deviant patterns in neurometric data including EEG…
ID
Source
Brief title
Condition
- Developmental disorders NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Depressive complaints: SCL-90 scores
Sensory processing:AASP scores
mindfulness skills: FFMQ scores
interpersonal functioning and functioning in society : OQ-45 scores
neurometric measures:
* quantitative EEG (qEEG); spectral parameters; coherence measures
* Event Related Potentials measures: latency/amplitude N2/P3 components
* neuropsychological measures (reaction times, error rates etc.)
* autonomous nervous system measures (heart rate variability, electrodermal
activity)
Secondary outcome
N/A
Background summary
Adults with autism spectrum disorder (ASD) experience often and much
psychological problems in social life. This frequently leads to depressive
symptoms. Moreover, adult ASD patients often suffer from sensory overload. To
date, no scientific studies have been published on how to adequately treat
these serious problems in ASD patients. However, there is literature that
indicates that Mindfulness treatment can achieve positive results in other
patient groups suffering from depression. The current project aims at
evaluating the effect of Mindfulness Based Cognitive Therapy (MBCT) in adult
ASD patients. For this purpose, neuropsychological tests and questionaires will
be used as well as measurement of neurometric variables such as quantitative
EEG (qEEG) measures, Event Related Potentials, heart rate variability and
electrodermal activity. As reference, the same measurements will be done in a
control group of neurotypical volunteers.
Study objective
Answering four research questions:
• Do adults with ASD report less complaints of depression after the mindfulness
training when compared to prior the training?
• Do adults with ASD have significant deviant patterns in neurometric data
including EEG during rest and during task performance and ERPs when compared to
an age-matched neurotypical control group
• Are adults with ASD less oversensitive to sensory stimuli after MBCT training
when compared to prior the training
• Do adults with ASD show less deviant neurometic characteristics after the
mindfulness training when compared to prior the training.
Study design
This is a cross-over study where three patient groups, each comprising of 15
participants undergo the same protocol:
1) a baseline measurement/recording (M0)
2) a second measurement/recording (M1)
3) start of the MBCT directly after M1
4) MBCT during 9 weeks
5) third measurement/recording after end of the training (M2)
Start of the protocol for each of the patient groups is 9 weeks apart from each
other.
In addition, the measurement/recording protocol is applied in a healthy
controls group of 15 age and gender matched volunteers at the beginning of the
project.
Intervention
individual weekly MBCT sessions (2 hrs). Client has to excercise at least 6
days/wk
Study burden and risks
Risks: not applicable
All treatment groups:
* questionaires: reference (null) recording: 1 hour; pre-recording: 1 hour;
final recording: 1 hour
* training MBCT: 9 weekly sessions; each 2.5 hours
* home exercises MBCT: 9 weeks, 6 days/week, 1 hour /day
Additional burden for participants in the extended protocol (incl neurometry):
* initial recording: 1 hour neurometric recordings
* effect recording: 1 hour neurometric recordings
Boschdijk 771
5626 AB Eindhoven
NL
Boschdijk 771
5626 AB Eindhoven
NL
Listed location countries
Age
Inclusion criteria
Treatment groups meet DSM-IV/TR and ADI-R criteria for autistic disorder or Asperger disorder. Age 18-60. WAIS-III IQ score >85. Suffer from depressive complaints and/or sensory over-excitability
Control group: matched on gender and age.
Exclusion criteria
Treatment group: no comorbid neuropsychiatric disorders such as substance abuse, epilepsy, neuropathologies
Control group: no known neuropsychiatric disorders such as depression, addiction, epilepsy, neuropathology; use of psycho-active medication.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL29437.097.09 |